(Q36902027)

17 August 2017

1 reference

title

When attention-deficit/hyperactivity disorder co-occurs with anxiety disorders: effects on treatment (English)

1 reference

attention deficit hyperactivity disorder

17 August 2017

1 reference

1 reference

Katharina Manassis

1

1 reference

17 August 2017

publication date

1 August 2007

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

17 August 2017

published in

1 reference

17 August 2017

volume

7

1 reference

17 August 2017

issue

8

1 reference

17 August 2017

page(s)

981-988

1 reference

Comorbidity in ADHD: implications for research, practice, and DSM-V.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Anxiety disorders in an attention-deficit/hyperactivity disorder clinical sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Correlates of ADHD among children in pediatric and psychiatric clinics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Comorbidity of attention-deficit hyperactivity disorder and overanxious disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Variations in anxiety and depression as a function of ADHD subtypes defined by DSM-IV: do subtype differences exist or not?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Cognition in anxious children with attention deficit hyperactivity disorder: a comparison with clinical and normal children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Synaptic gating and ADHD: a biological theory of comorbidity of ADHD and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Dichotic listening and response inhibition in children with comorbid anxiety disorders and ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Relationship between ADHD and anxiety in boys: results from a family study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Family correlates of comorbid anxiety disorders in children with attention deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Attention deficit hyperactivity disorder and anxiety: is there an association with neurodevelopmental deficits?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

ADHD with comorbid anxiety: a review of the current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Response inhibition and response re-engagement in attention-deficit/hyperactivity disorder, disruptive, anxious and normal children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Response inhibition in AD/HD, CD, comorbid AD/HD + CD, anxious, and control children: a meta-analysis of studies with the stop task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Performance monitoring and response inhibition in anxiety disorders with and without comorbid ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Effect of anxiety on cognition, behavior, and stimulant response in ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

The relation between sluggish cognitive tempo and DSM-IV ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Pharmacotherapy of attention-deficit/hyperactivity disorder: nonstimulant medication approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Examining outcome variability: correlates of treatment response in a child and adolescent anxiety clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Remission versus response as the goal of therapy in ADHD: a new standard for the field?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Abnormal attention modulation of fear circuit function in pediatric generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Sluggish cognitive tempo predicts a different pattern of impairment in the attention deficit hyperactivity disorder, predominantly inattentive type

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Revisiting the association between attention-deficit/hyperactivity disorder and anxiety disorders: a familial risk analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

Characteristics of Parent- and Child-Reported Anxiety in Psychostimulant Medication Naïve, Clinically Referred Children with Attention Deficit Hyperactivity Disorder, Combined Type (ADHD-CT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.8.981

21 January 2018

Identifiers

DOI

10.1586/14737175.7.8.981

1 reference

17 August 2017

1 reference